Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression

<p dir="ltr">Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related morbidity and mortality worldwide. Immune checkpoint inhibitors (ICIs) including anti-PD-1 and anti-PD-L1 antibodies, have significantly changed the treatment outcomes with better overall survival,...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Afsheen Raza (492657) (author)
مؤلفون آخرون:	Reyad Mohsen (14778049) (author), Aladdin Kanbour (14442123) (author), Abdul Rehman Zar Gul (14777347) (author), Anite Philip (14442129) (author), Suma Vijayakumar (14442132) (author), Shereena Hydrose (14442135) (author), Kirti S. Prabhu (4246144) (author), Aisha Khamis Al-Suwaidi (18021682) (author), Varghese Philipose Inchakalody (14153292) (author), Maysaloun Merhi (4246147) (author), Dina M. Abo El-Ella (18021685) (author), Melissa Annrose Tauro (18021688) (author), Shayista Akbar (14442117) (author), Issam Al-Bozom (4711098) (author), Wafa Abualainin (14442141) (author), Rajaa Al-Abdulla (14442138) (author), Shaza Abu Sirriya (18021691) (author), Suparna Hassnad (18021694) (author), Shahab Uddin (154400) (author), Mohamed Izham Mohamed Ibrahim (14158896) (author), Ussama Al Homsi (14442150) (author), Said Demime (18021697) (author)
منشور في:	2023
الموضوعات:	Biomedical and clinical sciences Immunology Oncology and carcinogenesis non-small cell lung cancer anti-PD-1 anti-PD-L1 tissue PD-L1 predictive soluble biomarkers CEA
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression

مواد مشابهة